N-[[[9-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-L-threonine

N-[[[9-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-L-threonine Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N-[[[9-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-L-threonine is an intermediate used in the synthesis of N6-(N-Threonylcarbonyl)adenosine (T405560), which is an essential modified nucleoside found in tRNA responsible for ANN codons in all three domains of life. It is also a biological marker in neoplastic diseases.

N-[[[9-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-L-threonine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-[[[9-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-L-threonine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19743	58
BOC Sciences	16314854226	inquiry@bocsci.com	United States	9713	58
Beijing Qinling Pharmaceutical Co., Ltd.	010 61241352 18901327973	834537306@qq.com	China	3798	58

---

• N-[[[9-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-L-threonine
• L-Threonine, N-[[[9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-
• N-[[[9-(2,3,5-Tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-6-yl]amino]carbonyl]-L-threonine
• N-[9-(tri-O-acetyl-β-D-ribofuranosyl)-purin-6-ylcarbamoyl]-threonine
• 56893-27-7
• C21H26N6O11